Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 2, 2016, Pages 258-265

  Malvehy, J ^a,b,c   Alarcon, I ^a,d   Montoya, J ^a   Rodriguez Azeredo R ^d   Puig, S ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Almirall SA ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; SALICYLIC ACID; IMMUNOSUPPRESSIVE AGENT; KERATOLYTIC AGENT;

ACTINIC KERATOSIS; AGED; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; LOW DRUG DOSE; MALE; MEASUREMENT; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLECTANCE CONFOCAL MICROSCOPY; STRATUM CORNEUM; TREATMENT OUTCOME; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; EPILUMINESCENCE MICROSCOPY; FEMALE; FOLLOW UP; IMAGE ENHANCEMENT; KERATOSIS, ACTINIC; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; DERMOSCOPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMMUNOSUPPRESSIVE AGENTS; KERATOLYTIC AGENTS; KERATOSIS, ACTINIC; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SALICYLIC ACID; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84956604634     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13445     Document Type: Article

References (30)

1. Callen JP, Bickers DR, Moy RL,. Actinic keratoses. J Am Acad Dermatol 1997; 36: 650-653.
2. Flohil SC, van der Leest RJT, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T,. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971-1978.
3. Feldman SR, Fleischer AB Jr,. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201-207.
4. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma "actinic keratosis". J Am Acad Dermatol 2000; 42: 11-17.
5. Slaughter DP, Southwick HW, Smejkal W,. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953; 6: 963-968.
6. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
7. Tabor MP, Brakenhoff RH, van Houten VM, et al,. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001; 7: 1523-1532.
8. Partridge M, Li SR, Pateromichelakis S, et al,. Detection of minimal residual cancer to investigate why oral tumours recur despite seemingly adequate treatment. Clin Cancer Res 2000; 6: 2718-2725.
9. Ulrich M, Maltusch A, Rius-Diaz F, et al,. Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg 2008; 34: 610-619.
10. Richtig E, Ahlgrimm-Siess V, Koller S, et al,. Follow-up of actinic keratoses after shave biopsy by in-vivo reflectance confocal microscopy-a pilot study. J Eur Acad Dermatol Venereol 2010; 24: 293-298.
11. Peppelman M, Nguyen KP, Hoogedoorn L, van Erp PE, Gerritsen MJ,. Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma. J Eur Acad Dermatol Venereol 2015; 2: 2302-1309.
12. Boone MA, Norrenberg S, Jemec GB, Del Marmol V,. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study. Exp Dermatol 2013; 22: 93-97.
13. Aghassi D, Anderson RR, González S,. Confocal laser microscopic imaging of actinic keratoses in vivo: a preliminary report. J Am Acad Dermatol 2000; 43 (1 Pt 1): 42-48.
14. Ulrich M, Maltusch A, Röwert-Huber J, et al,. Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol 2007; 156 (Suppl 3): 13-17.
15. Ulrich M, Krueger-Corcoran D, Roewert-Huber J, Sterry W, Stockfleth E, Astner S,. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses. Dermatology 2010; 220: 15-24.
16. Malvehy J, Roldán-Marín R, Iglesias-García P, Díaz A, Puig S,. Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation. Acta Derm Venereol 2015; 95: 45-50.
17. Maier T, Cekovic D, Ruzicka T, Sattler E, Berking C,. Treatment monitoring of topical ingenol mebutate in actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy: a case series. Br J Dermatol 2015; 172: 816-818.
18. Olsen EA, Abernethy ML, Kulp-Shorten C, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24 (5 Pt 1): 738-743.
19. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR,. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol 1995; 104: 946-952.
20. Rishpon A, Kim N, Scope A, et al,. Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses. Arch Dermatol 2009; 145: 766-772.
21. Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C,. Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol 2013; 168: 120-128.
22. Stockfleth E, Kerl H, Zwingers T, Willers C,. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol 2011; 165: 1101-1108.
23. Simon JC, Dominicus R, Karl L, Rodríguez R, Willers C, Dirschka T,. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis. J Eur Acad Dermatol Venereol 2015; 29: 881-889.
24. Nieves D, Puig-Peirõ R, Ferrándiz C, Plazas MJ, Brosa M,. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain. Expert Rev Pharmacoecon Outcomes Res 2015; 15: 539-543.
25. Ulrich M, Alarcon I, Malvehy J, Puig S,. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis. Dermatology 2015; 230: 193-198.
26. Fernández-Figueras MT, Carrato C, Sáenz X, et al,. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol 2015; 29: 991-997.
27. Stockfleth E, Ferrandiz C, Grob JJ, et al,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
28. Malvehy J,. A new vision of actinic keratosis beyond visible clinical lesions. J Eur Acad Dermatol Venereol 2015; 29 (Suppl 1): 3-8.
29. Boone MA, Marneffe A, Suppa M, et al,. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma. J Eur Acad Dermatol Venereol 2015; 29: 1606-1615.
30. Maier T, Kulichova D, Ruzicka T, Berking C,. Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumour regression. J Am Acad Dermatol 2014; 71: 725-730.